Santen Worldwide. Santen Pharmaceutical offers innovative ophthalmic products and a clear vision for life to people throughout the world.
Employees: 1001-5000
Founded date: 1890
Investors 1
| Date | Name | Website |
| - | Auriga Par... | auriga.vc |
Mentions in press and media 13
| Date | Title | Description |
| 17.10.2025 | TraceLink Ushers in the Agentic Industrial Revolution to Transform Healthcare and Life Sciences Operations for Global Supply Chains | Introducing Agentic Orchestration: Where Digital Experts Perceive, Reason, and Act BOSTON, Oct. 17, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, announced... |
| 19.08.2025 | RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries | YANTAI, China, Aug. 19, 2025 /PRNewswire/ -- RemeGen Co., Ltd. (Stock Code: 688331.SH/09995.HK, "RemeGen"), a leading Chinese biopharmaceutical company, announced today that it has entered into an agreement with Santen Pharmaceuti... |
| 16.04.2024 | Santen Pharmaceutical Co., Ltd. Santen completes new factory “Santen Vision Park” for further growth in Ch ina | - |
| 25.03.2024 | Santen Pharmaceutical Co., Ltd. Notice regarding change of representative director | - |
| 25.03.2024 | Santen Pharmaceutical Co., Ltd. Notice regarding change of representative director | Santen Pharmaceutical Co., Ltd. Notice regarding change of representative director …… On March 25, 2024, Santen Pharmaceutical Co., Ltd. (Headquarters: Osaka City, hereinafter referred to as Santen) received a notification from Akira Kuroka... |
| 27.12.2022 | Prevent Blindness Invites Patients and Caregivers to Join The Glaucoma Community as Part of January’s National Glaucoma Awareness Month | Prevent Blindness invites public to join "The Glaucoma Community" as part of January's National Glaucoma Awareness Month. “We invite patients, caregivers and professionals to join The Glaucoma Community today to get the support an... |
| 08.11.2021 | Santen Reports the 2nd Quarter Fiscal 2021 Consolidated Performance | Summary of Consolidated Financial Results for the Six Months Ended September 30, 2021 (IFRS) Listed Company Name: Santen Pharmaceutical Co.,Ltd Exchanges Listed: Tokyo (First section) Stock Code: 4536 URL: https://www.santen.com Representat... |
| 04.02.2020 | Verily Launches Joint Venture to Develop & Commercialize Ophthalmic Devices | – Alphabet company Verily and Santen Pharmaceutical launch joint venture focused on developing and commercializing ophthalmic devices and comprehensive tech-enabled solutions. – The joint venture will focus on tackling ophthalmic conditions... |
| 09.11.2011 | FDA says no to Merck oral contraceptive, eye treatment drugs for now | The company is also discontinuing the clinical development program for MK-0431C, a diabetes treatment that combines sitagliptin and pioglitazone, a move “based on a review of the regulatory and commercial prospects for the combination drug ... |
| 30.03.2011 | Dry eye drug from Inspire gets patent extension in Japan | Diquafosol tetrasodium, marketed as Diquas, was launched in December by Japan-based drug partner Santen Pharmaceutical Co. Inspire and Santen entered into an agreement in 1998 that gave Santen an exclusive license to develop and market Diqu... |
Show more